• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges.

作者信息

Virani Salim S

机构信息

Health Policy & Quality Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center of Excellence, Methodist DeBakey Heart & Vascular Center, Houston, Texas 77030, USA.

出版信息

Tex Heart Inst J. 2011;38(2):160-2.

PMID:21494527
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3066801/
Abstract
摘要

相似文献

1
Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges.非高密度脂蛋白胆固醇作为优质医疗指标：机遇与挑战。
Tex Heart Inst J. 2011;38(2):160-2.
2
Atherogenic dyslipidemia in the cardiometabolic syndrome.心血管代谢综合征中的致动脉粥样硬化性血脂异常
J Cardiometab Syndr. 2006 Spring;1(2):153-5. doi: 10.1111/j.1559-4564.2006.05671.x.
3
Atherogenic dyslipidemia.致动脉粥样硬化性血脂异常
J Cardiometab Syndr. 2006 Summer;1(3):166-7.
4
Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.低高密度脂蛋白胆固醇是低密度脂蛋白胆固醇得到最佳控制的稳定冠状动脉疾病糖尿病患者长期临床结局的一个残余危险因素。
Heart Vessels. 2014 Jan;29(1):35-41. doi: 10.1007/s00380-013-0330-5. Epub 2013 Mar 21.
5
Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.降脂治疗患者的每日血糖波动对冠状动脉斑块易损性的影响：一项前瞻性观察研究。
JACC Cardiovasc Interv. 2015 May;8(6):800-811. doi: 10.1016/j.jcin.2014.11.025.
6
Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention.脂蛋白比率：在心血管疾病预防中的生理意义及临床应用价值
Vasc Health Risk Manag. 2009;5:757-65. Epub 2009 Sep 18.
7
Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impact.稳定型冠状动脉疾病患者的低密度脂蛋白胆固醇治疗目标达标情况：决定因素和预后影响。
Arch Cardiovasc Dis. 2018 Nov;111(11):634-643. doi: 10.1016/j.acvd.2017.07.007. Epub 2017 Dec 2.
8
Dyslipidaemias in 2017: Atherogenic lipoproteins as treatment targets.2017年血脂异常：致动脉粥样硬化脂蛋白作为治疗靶点。
Nat Rev Cardiol. 2018 Jan 16;15(2):75-76. doi: 10.1038/nrcardio.2017.221.
9
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.缓释烟酸/拉罗匹仑、辛伐他汀及其联合用药对血脂异常患者载脂蛋白B、低密度脂蛋白胆固醇和非高密度脂蛋白胆固醇之间相关性的影响。
Vasc Health Risk Manag. 2014 May 7;10:279-90. doi: 10.2147/VHRM.S58694. eCollection 2014.
10
[Treatment of dyslipidemia in 2014: European versus American guidelines].《2014年血脂异常的治疗：欧洲与美国指南对比》
Rev Med Suisse. 2014 Aug 27;10(439):1534-7.

引用本文的文献

1
Obesity phenotypes and dyslipidemia in adults from four African countries: An H3Africa AWI-Gen study.四个非洲国家成年人的肥胖表型与血脂异常：一项H3Africa AWI-Gen研究
PLoS One. 2025 Jan 30;20(1):e0316527. doi: 10.1371/journal.pone.0316527. eCollection 2025.
2
Glucose and Lipid Metabolism Disorders in Adults with Spinal Muscular Atrophy Type 3.3型脊髓性肌萎缩症成人患者的糖脂代谢紊乱
Diagnostics (Basel). 2024 Sep 19;14(18):2078. doi: 10.3390/diagnostics14182078.
3
The performance of lipid profiles and ratios as a predictor of arterial stiffness measured by brachial-ankle pulse wave velocity in type 2 diabetic patients.血脂谱和比值作为 2 型糖尿病患者肱踝脉搏波速度测量的动脉僵硬度预测指标的性能。
F1000Res. 2023 Jun 5;11:1582. doi: 10.12688/f1000research.128627.2. eCollection 2022.
4
Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond.靶向低密度脂蛋白胆固醇的进展：前蛋白转化酶枯草杆菌蛋白酶/kexin 9型抑制剂及其他。
Am J Prev Cardiol. 2024 Jun 25;19:100701. doi: 10.1016/j.ajpc.2024.100701. eCollection 2024 Sep.
5
Physical activity in metabolic syndrome.代谢综合征中的身体活动
Front Physiol. 2024 Feb 19;15:1365761. doi: 10.3389/fphys.2024.1365761. eCollection 2024.
6
Factors Affecting Dyslipidemia among Korean Adolescents: An Analysis Using the 8th Korea National Health and Nutrition Examination Survey (2021).韩国青少年血脂异常的影响因素：基于第八次韩国国家健康与营养检查调查（2021年）的分析
Children (Basel). 2023 Sep 28;10(10):1618. doi: 10.3390/children10101618.
7
Influence of 24-Week Yoga Intervention on Cardiovascular Risk Factors and Inflammatory Markers in Type 2 Diabetes.24周瑜伽干预对2型糖尿病患者心血管危险因素及炎症标志物的影响
Int J Yoga. 2023 Jan-Apr;16(1):27-33. doi: 10.4103/ijoy.ijoy_176_22. Epub 2023 Jul 10.
8
Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: an implementation study.在黎巴嫩长期人道主义危机中用于心血管疾病的固定剂量复方药物：一项实施研究。
BMJ Open. 2023 Jan 25;13(1):e063668. doi: 10.1136/bmjopen-2022-063668.
9
Non-HDL-C and LDL-C/HDL-C are associated with self-reported cardiovascular disease in a rural West African population: Analysis of an array of lipid metrics in an AWI-Gen sub-study.非高密度脂蛋白胆固醇和低密度脂蛋白胆固醇/高密度脂蛋白胆固醇与农村西非人群的自我报告心血管疾病相关：AWI-Gen 子研究中一系列血脂指标的分析。
PLoS One. 2022 Dec 7;17(12):e0278375. doi: 10.1371/journal.pone.0278375. eCollection 2022.
10
COVID-19 and related social distancing measures induce significant metabolic complications without prominent weight gain in Korean adults.新型冠状病毒肺炎（COVID-19）及相关社交距离措施在韩国成年人中引发了显著的代谢并发症，但体重并未明显增加。
Front Med (Lausanne). 2022 Sep 7;9:951793. doi: 10.3389/fmed.2022.951793. eCollection 2022.

本文引用的文献

1
Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines.根据成人治疗专家组 III 指南，机构、提供者和患者与低密度脂蛋白和非高密度脂蛋白胆固醇目标达标相关的因素。
Am Heart J. 2011 Jun;161(6):1140-6. doi: 10.1016/j.ahj.2011.03.023. Epub 2011 May 11.
2
The importance of non-HDL cholesterol reporting in lipid management.非高密度脂蛋白胆固醇报告在血脂管理中的重要性。
J Clin Lipidol. 2008 Aug;2(4):267-73. doi: 10.1016/j.jacl.2008.06.013. Epub 2008 Jun 28.
3
Major lipids, apolipoproteins, and risk of vascular disease.主要脂质、载脂蛋白与血管疾病风险
JAMA. 2009 Nov 11;302(18):1993-2000. doi: 10.1001/jama.2009.1619.
4
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.他汀类药物治疗中脂质、载脂蛋白及其与心血管事件的关系
Circulation. 2008 Jun 10;117(23):3002-9. doi: 10.1161/CIRCULATIONAHA.107.713438. Epub 2008 Jun 2.
5
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.心血管代谢风险患者的脂蛋白管理：美国糖尿病协会和美国心脏病学基金会共识会议报告
J Am Coll Cardiol. 2008 Apr 15;51(15):1512-24. doi: 10.1016/j.jacc.2008.02.034.
6
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.国家胆固醇教育计划（NCEP）利用新型电子技术（NEPTUNE）II 调查的结果以及近期 NCEP 写作小组建议下的治疗意义。
Am J Cardiol. 2005 Aug 15;96(4):556-63. doi: 10.1016/j.amjcard.2005.04.019.
7
Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.胰岛素抵抗动脉粥样硬化研究中代谢综合征患者载脂蛋白B和非高密度脂蛋白胆固醇与其他心血管危险因素的关联比较
Circulation. 2004 Oct 26;110(17):2687-93. doi: 10.1161/01.CIR.0000145660.60487.94. Epub 2004 Oct 18.
8
Intensive versus moderate lipid lowering with statins after acute coronary syndromes.急性冠状动脉综合征后使用他汀类药物强化降脂与中度降脂的比较。
N Engl J Med. 2004 Apr 8;350(15):1495-504. doi: 10.1056/NEJMoa040583. Epub 2004 Mar 8.
9
Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels.非高密度脂蛋白胆固醇与载脂蛋白B的相关性：5-羟甲基戊二酰辅酶A还原酶抑制剂对非高密度脂蛋白胆固醇水平的影响
Am J Cardiol. 2001 Aug 1;88(3):265-9. doi: 10.1016/s0002-9149(01)01638-1.
10
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).国家胆固醇教育计划（NCEP）成人高血胆固醇检测、评估与治疗专家小组第三次报告（成人治疗小组第三次报告）执行摘要
JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.